Literature DB >> 23661571

Q-ing for health--a new approach to eliciting the public's views on health care resource allocation.

Rachel Baker1, John Wildman, Helen Mason, Cam Donaldson.   

Abstract

The elicitation of societal views about healthcare priority setting is an important, contemporary research area, and there are a number of studies that apply either qualitative techniques or quantitative preference elicitation methods. However, there are methodological challenges in connecting qualitative information (what perspectives exist about a subject) with quantitative questions (to what extent are those perspectives 'supported' in a wider population). In this paper, we present an integrated, mixed-methods approach to the elicitation of public perspectives in two linked studies applying Q methodology. In the first study, we identify three broad viewpoints on the subject of health priorities. In the second study, using Q-survey methods, we describe and illustrate methods to investigate the distribution of those views in the wider population. The findings of the second study suggest that no single viewpoint dominates and none of the three views represents a 'minority perspective'. We demonstrate the potential of Q methodology as a methodological framework that can be used to link qualitative and quantitative questions and suggest some advantages of this over other approaches. However, as this represents the first applied study of this kind, there are methodological questions that require further exploration and development.
Copyright © 2013 John Wiley & Sons, Ltd.

Keywords:  Q methodology; QALYs; distributional justice; equity; social values; societal preferences

Mesh:

Year:  2013        PMID: 23661571     DOI: 10.1002/hec.2914

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  7 in total

1.  Good practice or positive action? Using Q methodology to identify competing views on improving gender equality in academic medicine.

Authors:  Louise D Bryant; Paula Burkinshaw; Allan O House; Robert M West; Vicky Ward
Journal:  BMJ Open       Date:  2017-08-22       Impact factor: 2.692

2.  Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC).

Authors:  Christel Protière; Bruno Spire; Marion Mora; Isabelle Poizot-Martin; Marie Préau; Marjolaine Doumergue; Philippe Morlat; David Zucman; Cécile Goujard; François Raffi; Olivier Lambotte; Marie Suzan-Monti
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

3.  Who should receive treatment? An empirical enquiry into the relationship between societal views and preferences concerning healthcare priority setting.

Authors:  Vivian Reckers-Droog; Job van Exel; Werner Brouwer
Journal:  PLoS One       Date:  2018-06-27       Impact factor: 3.240

4.  Q sample construction: a novel approach incorporating a Delphi technique to explore opinions about codeine dependence.

Authors:  Melissa Kirschbaum; Tony Barnett; Merylin Cross
Journal:  BMC Med Res Methodol       Date:  2019-05-14       Impact factor: 4.615

5.  A scoping review of Q-methodology in healthcare research.

Authors:  Kate Churruca; Kristiana Ludlow; Wendy Wu; Kate Gibbons; Hoa Mi Nguyen; Louise A Ellis; Jeffrey Braithwaite
Journal:  BMC Med Res Methodol       Date:  2021-06-21       Impact factor: 4.615

6.  Are life-extending treatments for terminal illnesses a special case? Exploring choices and societal viewpoints.

Authors:  Neil McHugh; Job van Exel; Helen Mason; Jon Godwin; Marissa Collins; Cam Donaldson; Rachel Baker
Journal:  Soc Sci Med       Date:  2017-12-16       Impact factor: 4.634

7.  Is "end of life" a special case? Connecting Q with survey methods to measure societal support for views on the value of life-extending treatments.

Authors:  Helen Mason; Marissa Collins; Neil McHugh; Jon Godwin; Job Van Exel; Cam Donaldson; Rachel Baker
Journal:  Health Econ       Date:  2018-01-19       Impact factor: 3.046

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.